Yinglong Q. Huang
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Commentary: Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation.
Journal: Frontiers in immunology
Published: July 01, 2026
Targeting the extracellular vesicle-immune axis in prostate cancer: mechanisms of immune evasion and emerging therapeutic strategies.
Journal: Biochemical pharmacology
Published: June 19, 2026
Immediate urinary continence after continence-preserving holmium laser enucleation versus transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia: a single-center comparative cohort study.
Journal: World journal of urology
Published: May 22, 2026
Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges.
Journal: International journal of nanomedicine
Published: April 08, 2026
Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer.
Journal: Translational oncology
Published: January 30, 2026
Construction of a gene-metabolite-microbiome regulatory network reveals novel therapeutic targets in bladder cancer through multi-omics analysis.
Journal: Annals of medicine
Published: September 05, 2025
Predictive value of neutrophil/lymphocyte ratio in the prognosis of primary biliary cholangitis
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: August 10, 2025
Silencing CALB1 enhances prostate cancer radiosensitivity via calcium-mediated mitochondrial dysfunction and cellular senescence.
Journal: Cell calcium
Published: April 29, 2025
Lymphadenectomy in upper tract urothelial carcinoma: Clinical insights and controversies (Review).
Journal: Oncology reports
Published: March 29, 2025
Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression.
Journal: European journal of medical research
Published: March 11, 2025
Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer.
Journal: Journal of inflammation research
Published: February 16, 2025
Last Updated: 09/26/2026